Here are the DEF 14A proxy statements from HealthEquity, Inc (HQY) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A DEF 14A covers the proxy statement, with executive pay and the shareholder votes, so if you follow HQY and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full HQY filings page.
HealthEquity, Inc. is asking stockholders to vote at a virtual annual meeting on June 25, 2026 on five key items, including electing ten directors, ratifying PricewaterhouseCoopers as auditor, an advisory say-on-pay vote, and approving a 2026 Employee Stock Purchase Plan and an amended 2024 Equity Incentive Plan.
The proxy highlights strong fiscal 2026 performance, with revenue of $1.313 billion, net income of $215.2 million and diluted EPS of $2.46, alongside Adjusted EBITDA of $566.0 million. Operationally, the company ended the year with 10.6 million health savings accounts, 17.8 million total accounts and $36.5 billion of HSA assets.
HealthEquity also reports repurchasing 3.3 million shares for $301.7 million and describes an extensive governance framework, including an independent chair, fully independent key committees, formal risk oversight (with a dedicated cybersecurity and technology committee), and a pay-for-performance executive compensation program emphasizing multi‑year, at‑risk equity, stock ownership guidelines, and a clawback policy.